Finland· FI-REL-REL61325

Tauvid

A flortaucipir (18f) product containing flortaucipir (18f), registered in Finland by Eli Lilly Nederland B.V. The same ATC class is registered in 7 of our 19 countries.

ATC V09AX07

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedTauvidATCV09AX07REGISTER NO.FI-REL-REL61325PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Flortaucipir (18f) is registered in 7 of 19 countries.

Countries holding a registration under ATC V09AX07 (flortaucipir (18f)), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 5 of them publish a price we can compare per daily dose

Flortaucipir (18f) · ATC V09AX07

7 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Flortaucipir (18F)
Manufacturer
Eli Lilly Nederland B.V
Country
Finland (FI)
ATC code
V09AX07
ATC class
Flortaucipir (18F)
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Flortaucipir (18f) in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All flortaucipir (18f) products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Tauvid
  • Liechtenstein · Tauvid
  • Norway · Tauvid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1cd282dc-659f-4188-97b2-d3cea05fefdb
GET /v1/drugs/1cd282dc-659f-4188-97b2-d3cea05fefdb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "injektioneste, liuos",
  "route": "Laskimoon",
  "ddd_unit": null,
  "strength": "800 MBq/ml",
  "atc_label": "flortausipiiri(18F)",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/1/24/1799/001",
  "fimea_rel_id": "REL61325",
  "authorised_at": "2024-08-22"
}

See everything about flortaucipir (18f).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.